Neonatal treatment with recombinant ectodysplasin prevents respiratory disease in dogs with X‐linked ectodermal dysplasia
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Patients with defective ectodysplasin A (EDA) have X‐linked hypohidrotic ectodermal dysplasia (XLHED; OMIM#305100), a condition comprising hypotrichosis, inability to sweat, abnormal teeth, and frequent pulmonary infections. The XLHED dogs show the same clinical signs as humans with the disorder, including frequent respiratory infections that can be fatal. The respiratory disease in humans and dogs is thought to be due to the absence of tracheal and bronchial glands which are a vital part of the mucociliary clearance mechanism. In our XLHED model, the genetically missing EDA was replaced by postnatal intravenous administration of recombinant EDA resulting in long‐term, durable corrective effect on adult, permanent dentition. After treatment with EDA, significant correction of the missing tracheal and bronchial glands was achieved in those dogs that received higher doses of EDA. Moreover, successful treatment resulted in the presence of esophageal glands, improved mucociliary clearance, and the absence of respiratory infection. These results demonstrate that a short‐term treatment at a neonatal age with a recombinant protein can reverse a developmental disease and result in vastly improved quality of life. © 2009 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kere, J., Srivastava, A. K., Montonen, O., Zonana, J., Thomas, N., Ferguson, B., Munoz, F., Morgan, D., Clarke, A., Baybayan, P., et al. (1996) · Nature Genetics · doi:10.1038/ng0895-409 · Cited by 749
Clinical aspects of X-linked hypohidrotic ectodermal dysplasia.
Clarke, A., Phillips, D. I., Brown, R., & Harper, P. S. (1987) · Archives of Disease in Childhood · doi:10.1136/adc.62.10.989 · Cited by 274
Cited by
The TNF Family of Ligands and Receptors: Communication Modules in the Immune System and Beyond
Dostert, C., Grusdat, M., Letellier, E., & Brenner, D. (2019) · Physiological Reviews · doi:10.1152/physrev.00045.2017 · Cited by 498
Modeling Recent Human Evolution in Mice by Expression of a Selected EDAR Variant
Kamberov, Y. G., Wang, S., Tan, J., Gerbault, P., Wark, A., Tan, L., Yang, Y., Li, S., Tang, K., Chen, H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.01.016 · Cited by 276
Prenatal correction of x-linked hypohidrotic ectodermal dysplasia
Schneider, H., Faschingbauer, F., Schuepbach-Mallepell, S., Körber, I., Wohlfart, S., Dick, A., Wahlbuhl, M., Kowalczyk-Quintas, C., Vigolo, M., Kirby, N., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1714322 · Cited by 183
Self-citationEctodysplasin A (EDA) – EDA receptor signalling and its pharmacological modulation
Kowalczyk-Quintas, C., & Schneider, P. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.01.004 · Cited by 97
Self-citationHypohidrotic ectodermal dysplasia: clinical and molecular review
Reyes‐Reali, J., Mendoza‐Ramos, M. I., Garrido‐Guerrero, E., Méndez‐Catalá, C. F., Méndez‐Cruz, A. R., & Pozo‐Molina, G. (2018) · International Journal of Dermatology · doi:10.1111/ijd.14048 · Cited by 101
Future developments in XLHED treatment approaches
Huttner, K. (2014) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36499 · Cited by 30
Metadata
- Authors
- Mauldin, E. A., Gaide, O., Schneider, P., & Casal, M. L.
- Venue
- American Journal of Medical Genetics Part A
- Publisher
- Wiley
- Published
- 2009-06-16
- Volume
- 149A
- Issue
- 9
- Pages
- 2045-2049
- ISSN
- 1552-4825 (ISSN-L)
- 1552-4833
- OpenAlex
- W1984177164
- Cited by
- 50
- References
- 2
- FWCI
- 1.08
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.